quantisnow
FeedTopReportsPricing
⌘K
Live feed
06:37:56·36d
SECFiling
Pelthos Therapeutics Inc. logo

SEC Form 10-K filed by Pelthos Therapeutics Inc.

PTHS· Pelthos Therapeutics Inc.
Health Care
Full content unavailable. See the original source below.
Original source

Companies

  • PTHS
    Pelthos Therapeutics Inc.
    Health Care

Recent analyst ratings

  • Apr 1UpdateCantor Fitzgerald$50.00
  • Feb 27UpdatePiper Sandler$48.00
  • Dec 3UpdateLake Street$50.00
  • Dec 3UpdateH.C. Wainwright$60.00
  • Nov 25UpdateRoth Capital$57.00
  • Sep 2UpdateOppenheimer$50.00

Related

  • INSIDER3d
    SEC Form 3 filed by new insider Gay John M.
  • SEC10d
    Pelthos Therapeutics Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
  • PR10d
    Pelthos Therapeutics to Participate in Piper Sandler Spring Biopharma Symposium
  • PR13d
    Pelthos Therapeutics Announces CFO Transition
  • SEC13d
    Pelthos Therapeutics Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits
  • INSIDER17d
    SEC Form 4 filed by Malamut Richard
  • INSIDER17d
    SEC Form 4 filed by Friedberg Ezra M
  • INSIDER17d
    SEC Form 4 filed by Pauls Matthew
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022